Connor, Clark & Lunn Investment Management Ltd.

Position in SNN — Smith & Nephew PLC

CIK 1596800 VANCOUVER, A1

Position in SNN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$14,052,767

+$9,990,248 QoQ

Shares Held

487,774

+204.5% QoQ

Ownership

0.117%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#20

of 292 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. SNN ranks #4 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC This page	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,052,767	487,774	+204.5%	Shares	Sole	2026-08-13
2024-03-31	$4,062,519	160,194	+52.6%	Shares	Sole	2024-05-09
2023-12-31	$2,862,872	104,944	+220.0%	Shares	Sole	2024-02-09
2023-09-30	$812,208	32,790	-87.9%	Shares	Sole	2023-11-13
2023-06-30	$8,749,779	271,311	-28.1%	Shares	Sole	2023-08-10
2023-03-31	$10,528,935	377,246	+522.7%	Shares	Sole	2023-05-10
2022-12-31	$1,629,157	60,586	-39.3%	Shares	Sole	2023-02-10
2020-12-31	$4,209,662	99,826	-57.2%	Shares	Sole	2021-02-16
2020-09-30	$9,119,527	233,236	+16.9%	Shares	Sole	2020-11-12
2020-06-30	$7,608,790	199,601	+8.4%	Shares	Sole	2020-08-13
2020-03-31	$6,605,855	184,161	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.